Results 91 to 100 of about 328,399 (303)

Long‐Term Outcomes of Reduced‐Intensity Conditioning Hematopoietic Stem Cell Transplantation for Patients With Systemic Sclerosis With Impaired Cardiac Function

open access: yesArthritis &Rheumatology, EarlyView.
Objective High‐intensity conditioning autologous hematopoietic stem cell transplantation (AHSCT) is standard of care for patients with advanced systemic sclerosis (SSc). The role of reduced‐intensity conditioning (RIC) before AHSCT in this population remains unclear.
Yonatan Lean   +4 more
wiley   +1 more source

Towards Phenotyping Characteristics and Mechanism of Conduction Delay in Patients With Nonischemic Heart Failure With Reduced Ejection Fraction: Insights From Cardiac Magnetic Resonance Imaging

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Considering that 30% to 40% of patients do not benefit from cardiac resynchronization therapy implantation, it is insufficient to evaluate patients with heart failure with reduced ejection fraction solely based on QRS duration and morphology ...
Di Zhou   +15 more
doaj   +1 more source

Heart Failure Treated with Low-dose Milrinone in a Full-term Newborn

open access: yesPrague Medical Report, 2012
A term newborn with a hypocontractile myocardium complicating persistent pulmonary hypertension of the newborn was successfully treated with a low-dose phosphodiesterase III inhibitor milrinone.
S. Šebková   +3 more
doaj   +1 more source

TWEAK/Fn14 Signaling Drives Oxidative Cardiac Injury in Systemic Lupus Erythematosus: Evidence From Patient Biomarker Studies, Lupus Mouse Models, and Cardiomyocyte Assays

open access: yesArthritis &Rheumatology, EarlyView.
Objective Cardiac involvement is a major cause of morbidity in systemic lupus erythematosus (SLE). Tumor necrosis factor–like weak inducer of apoptosis (TWEAK) is elevated in SLE, but its contribution to lupus‐associated cardiac injury is unclear. We investigated the role of TWEAK/fibroblast growth factor–inducible 14 (Fn14) signaling in SLE‐related ...
Yale Liu   +12 more
wiley   +1 more source

Effect of changes in contractility on the index of myocardial performance in the dysfunctional left ventricle

open access: yesCardiovascular Ultrasound, 2006
Background The index of myocardial performance has prognostic power in patients with cardiomyopathy and following myocardial infarction. As the index of myocardial performance has been shown to be preload and afterload dependent, the effect of altering ...
Lavine Steven J
doaj   +1 more source

SpartanAnatomy.org: Evaluating a new interactive neuroradiology tool for early medical education

open access: yesAnatomical Sciences Education, EarlyView.
Abstract Teaching neuroanatomy through the lens of magnetic resonance imaging (MRI) offers medical students a strong foundation for success. However, many existing MRI learning resources lack interactivity and user‐friendliness, require payment, or include an overwhelming number of labeled structures.
Halie Kerver   +3 more
wiley   +1 more source

Cardiogenic Shock Induced by Coronary Steal Syndrome Through a Neovessel of Mediastinal Neuroendocrine Tumor

open access: yesJACC: Case Reports, 2019
A woman was admitted for cardiogenic shock with a left ventricular ejection fraction of 15%. Coronary angiography showed a neovessel coursing superiorly toward a mediastinal mass.
Olivier Lairez, MD, PhD   +2 more
doaj   +1 more source

Left Ventricular Ejection Fraction in Heart Failure [PDF]

open access: yesEuropean Cardiology Review, 2018
Josep, Lupón, Antoni, Bayes-Genis
openaire   +2 more sources

Left ventricular ejection fraction: clinical, pathophysiological, and technical limitations

open access: yesFrontiers in Cardiovascular Medicine
Risk stratification of cardiovascular death and treatment strategies in patients with heart failure (HF), the optimal timing for valve replacement, and the selection of patients for implantable cardioverter defibrillators are based on an echocardiographic calculation of left ventricular ejection fraction (LVEF) in most guidelines.
Vancheri, Federico   +2 more
openaire   +4 more sources

Blood pressure effects of SGLT2 inhibitors and GLP‐1 receptor agonists: Mechanisms, trial evidence and Real‐world data

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
SGLT2 inhibitors and GLP‐1 receptor agonists modestly lower blood pressure across diverse patient populations, including those without diabetes. These effects appear largely independent of glycaemic control and offer additive value in high‐risk patients with overlapping comorbidities.
Andrej Belančić   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy